PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcclpaBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Clinical Pathology
 
BMC Clin Pathol. 2013; 13: 4.
Published online 2013 February 5. doi:  10.1186/1472-6890-13-4
PMCID: PMC3568416

13-year-old tuberous sclerosis patient with renal cell carcinoma associated with multiple renal angiomyolipomas developing multifocal micronodular pneumocyte hyperplasia

Abstract

Background

The autosomal dominant tumor syndrome tuberous sclerosis complex is caused by the mutated TSC1 gene, hamartin, and the TSC2 gene, tuberin. Patients with this complex develop typical cutaneus symptoms such as peau chagrin or angiofibromas of the skin as well as other lesions such as astrocytomas in the brain and lymphangioleiomyomatosis in the lung. Only a few tuberous sclerosis patients have been described who showed a multifocal micronodular pneumocyte hyperplasia of the lung. Another benign tumor which often occurs together with tuberous sclerosis is the angiomyolipoma of the kidney. Furthermore, an increased incidence of renal cell carcinoma in connection with tuberous sclerosis has also been proven.

Case presentation

We report a 13-year-old white girl with epilepsy and hypopigmented skin lesions. Radiological studies demonstrated the typical cortical tubers leading to the diagnosis of tuberous sclerosis. In the following examinations a large number of angiomyolipomas were found in both kidneys. One lesion showed an increasing size and tumor like aspects in magnetic resonance imaging. The pathological examination of the following tumorectomy demonstrated an unclassified renal cell carcinoma. Four months postoperatively, a follow-up computer tomography revealed multiple bilateral pulmonary nodules. To exclude lung metastases of the renal cell carcinoma, multiple open-lung biopsies were performed.

Conclusion

Here we report a diagnostically challenging case of a 13-year-old patient with tuberous sclerosis and angiomyolipomas of the kidney who developed an unclassified renal cell carcinoma as well as multifocal micronodular pneumocyte hyperplasia.

Keywords: Multifocal micronodular pneumocyte hyperplasia (MMPH), Renal cell carcinoma, Angioleiomyolipoma, Tuberous sclerosis complex

Background

The TSC1 gene, hamartin, and the TSC2 gene, tuberin, were identified in 1997 and 1993, respectively. These tumor suppressor genes are mutated in the autosomal dominant tumor syndrome tuberous sclerosis complex (TSC) [1-3]. TSC is characterized by the formation of hamartomatous lesions in multiple organ systems. Besides the typical skin manifestations, e.g. cutaneous angiofibroma, peau chagrin, or subungual fibromas, TSC patients develop numerous brain lesions such as cortical tubers and subependymal giant cell astrocytomas. In addition, patients show an increased incidence of benign tumors such as multiple renal angiomyolipomas (AMLs), lymphangioleiomyomatosis (LAM) of the lungs, cardiac rhabdomyomas, and adenomatous polyps of the duodenum and the small intestine. Another rare manifestation of TSC is the so-called multifocal micronodular pneumocyte hyperplasia (MMPH), first recognized in 1991 by HH Popper [4]. TSC is also associated with an increased incidence of renal cell carcinomas (RCC) [5].

In this report, we present a case of a young patient with TSC and multiple AMLs who developed a RCC as well as MMPH. We discuss the histological, immunohistological and molecular features of these lesions with emphasis on the diagnostic requirements and differential diagnosis.

Case presentation

Clinical findings

The patient was a 13-year-old Caucasian girl who suffered from epilepsy in the form of salaam seizures that had begun at the age of 6 months. Aside from the seizures, clinical examination revealed hypopigmented skin lesions on the face and abdomen which were classified as peau chagrin. In addition, radiologic studies demonstrated the typical cortical tubers which led to the diagnosis of TSC. In the annual follow-up routine examinations, a large number of blurred coin lesions in both kidneys were found which were classified as multiple AMLs in the context of TSC. At the age of 13, one coin lesion showed an increase in size and magnetic resonance imaging (MRI) demonstrated a 3.5-cm tumor in the left kidney (Figure (Figure1A1A and B), upon which the the patient underwent tumorectomy of that kidney. The postoperative period was uneventful and the patient was discharged 7 days after surgery. Four months postoperatively, a follow-up CT scan of the chest revealed multiple bilateral pulmonary nodules measuring 1–6 mm (Figure (Figure2A).2A). Due to the RCC diagnosis, and also to rule out lung metastases, follow-up chest CT scans were performed after 6 and 9 months, showing an unchanged status of the pulmonary nodules in terms of size and number, with CT-morphological appearances typical of MMPH.One year after the renal tumor resection, multiple open lung biopsies of both lungs were performed to obtain histological evidence. After an uneventful recovery the patient was discharged after 5 days.

Figure 1
Morphology of renal tumors. A coronary (A) and axial (B) magnetic resonance imaging (MRI) scan of the kidneys showing multiple cysts and a tumor in the left kidney measuring 3.5 cm in diameter. Histologically, the renal cell carcinoma was composed of ...
Figure 2
Morphology of pulmonary lesions. Axial (A) computer tomography (CT) of the chest revealed multiple soft tissue density nodules of 1–6 mm in diameter in both lungs with a minimal peripheral ground glass component in a random peribronchovascular-centrilobular ...

Pathological findings of the renal tumors

Macroscopically, the tumorectomy revealed a 5 cm yellowish red tumor with multiple 1 to 2 mm yellow nodules in the adjacent kidney tissue.

The 5 cm tumor of the kidney showed a solid and nested, sometimes papillary architecture, and was composed of clear cells with voluminous cytoplasm, discrete cell borders, and vesicular chromatin. In addition, psammomatous calcification and hyaline nodules could be detected (Figure (Figure1C).1C). Immunohistochemical examinations revealed a weak to strong staining for vimentin and CD10 in more than 50% of neoplastic cells. All tumor cells showed a strong staining for P504s (Figure (Figure1D).1D). Pan-CK was only weakly expressed in scattered tumor cells. CK7 or HMB-45 could not be shown in the carcinoma cells. Based on the morphological and immunohistochemical findings, it was hypothesized that the tumor might be a RCC of XP 11.2 translocation type. This hypothesis was confirmed by three independent consultant pathologists (Leuschner I, Department of Pathology, University of Kiel, Germany; Moch H, Department of Surgical Pathology, University of Zürich, Switzerland; and Argami P, Department of Pathology, The Johns Hopkins University, Baltimore, USA); however, a typical expression of TFE3 and TFEB could not be demonstrated. Comparative genome hybridization (CGH) analysis did not reveal chromosomal imbalances such as losses at 3p or gains at 17q specific for clear cell RCC or papillary RCC, respectively (data not shown).

Besides the 5 cm tumor, multiple 1 to 2 mm nodules were observed in the adjacent renal tissue, which showed the 3 components of AMLs and the typical immunohistochemically expression of HMB-45 (Figure (Figure1E1E and F).

Pathological findings of the lung tumors

Macroscopically, open-lung biopsies revealed 2 to 5 mm sharply demarcated and randomly distributed nodules in both lungs (Figure (Figure22A).

The nodules were composed of proliferated and enlarged type II pneumocytes which had abundant eosinophilic cytoplasm and vesicular nuclei with prominent nucleoli and occasional eosinophilic inclusions. The cells formed ill-defined areas of papillae that filled the alveolar space and partly obscured the alveolar architecture. Significant atypia or mitosis could not be observed. The interalveolar septa were mild thickened with increased reticulin (Figure (Figure2B,2B, C, E, G). Immunohistochemically, the hyperplastic epithelial cells showed an expression of pan-CK, TTF-1 (Figure (Figure2D,2D, F), and EMA, whereas stains for HMB-45, actin, vimentin and ER were uniformly negative. The proliferation rate evaluated with MIB-1 was solely 2% (Figure (Figure22H).

Conclusion

TSC is an autosomal-dominant disorder characterized by a variably high incidence (90-95%) affecting 0.5-1 per 10,000 births. The diagnosis of TSC is currently made by using the criteria established by Gomez [6]. These criteria are composed of primary (e.g. subependymal nodes and facial angiofibroma), secondary, (e.g. AMLs and LAM), and tertiary features (e.g. hypomelanotic maculas). Whereas the hamartomas in TSC are benign lesions, other phakomatoses such as Von-Hippel-Lindau (VHL) disease are characterized by the development of malignant tumors. Therefore, RCC is a typical malignant tumor that is known to arise in VHL, whereas tuberous TSC patients also develop RCC, but only in rare cases [5]. The mechanisms behind the occurrence of RCC could be demonstrated in the Eker rat model which develops RCCs based on a mutation in TSC2 gene [7-9]. Furthermore, an unusual pulmonary manifestation of TSC is MMPH, typically presenting multiple pulmonary nodules on chest roentgenogram or CT scan [4,10,11].

The case described here shows the diagnostic challenge of young TSC patients who present with multiple AMLs of the kidney and develop an unclassified RCC. RCC often occur in young TSC patients [12,13] and demonstrate several subtypes [14]. In our case, in the follow-up months a CT scan revealed multiple nodules in the lungs. It is difficult to differentiate between benign lesions like LAM or MMPH and metastasis on the basis of CT scans only, as our present case demonstrates [15]. A definitive diagnosis of MMPH could only be made on the basis of histological examination of a lung biopsy. MMPH is extremely rare in TSC and in the literature less than 20 histologically documented cases are described and have been reported in association with LAM and AML [16]. One of these cases shows MMPH in a TSC patient who had undergone a bilateral nephrectomy because of RCC. AML are not reported in this case, but the authors also describe the difficulty they had differentiating between the benign MMPH and metastasis of the RCC [17].

The association between TSC mutation and RCC seems to be often underestimated in familiarly RCC [18]. Furthermore, the TSC 1/2 complex influences the beta-catenin pathway and could also play a functional role in other hereditary tumor syndromes such as Cowden’s disease or Peutz-Jeghers syndrome [19].

The case of a young TSC patient described here demonstrates a rare combination of AMLs, RCC and hamartomas in the lung, which posed a diagnostic dilemma.

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

CLB and SS constructed the manuscript and carried out the pathological examination. GS and CE were responsible for the radiological data. BG participated in pathological and genetic examination. HJR and FB were responsible for critical revision of the manuscript and have been involved in drafting it. All authors read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1472-6890/13/4/prepub

References

  • European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 1993;75:1305–1315. [PubMed]
  • Kandt RS, Haines JL, Smith M, Northrup H, Gardner RJ, Short MP, Dumars K, Roach ES, Steingold S, Wall S. et al. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet. 1992;2:37–41. doi: 10.1038/ng0992-37. [PubMed] [Cross Ref]
  • van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J. et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science. 1997;277:805–808. doi: 10.1126/science.277.5327.805. [PubMed] [Cross Ref]
  • Popper HH, Juettner-Smolle FM, Pongratz MG. Micronodular hyperplasia of type II pneumocytes–a new lung lesion associated with tuberous sclerosis. Histopathology. 1991;18:347–354. doi: 10.1111/j.1365-2559.1991.tb00856.x. [PubMed] [Cross Ref]
  • Bjornsson J, Short MP, Kwiatkowski DJ, Henske EP. Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features. Am J Pathol. 1996;149:1201–1208. [PubMed]
  • Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol. 1998;13:624–628. doi: 10.1177/088307389801301206. [PubMed] [Cross Ref]
  • Eker R. Familial renal adenomas in Wistar rats; a preliminary report. Acta Pathol Microbiol Scand. 1954;34:554–562. [PubMed]
  • Kobayashi T, Hirayama Y, Kobayashi E, Kubo Y, Hino O. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat Genet. 1995;9:70–74. doi: 10.1038/ng0195-70. [PubMed] [Cross Ref]
  • Yeung RS, Xiao GH, Jin F, Lee WC, Testa JR, Knudson AG. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci USA. 1994;91:11413–11416. doi: 10.1073/pnas.91.24.11413. [PubMed] [Cross Ref]
  • Guinee D, Singh R, Azumi N, Singh G, Przygodzki RM, Travis W, Koss M. Multifocal micronodular pneumocyte hyperplasia: a distinctive pulmonary manifestation of tuberous sclerosis. Mod Pathol. 1995;8:902–906. [PubMed]
  • Yamanaka A, Kitaichi M, Fujimoto T, Hirai T, Hori H, Konishi F. Multifocal micronodular pneumocyte hyperplasia in a postmenopausal woman with tuberous sclerosis. Virchows Arch. 2000;436:389–392. doi: 10.1007/s004280050464. [PubMed] [Cross Ref]
  • Al-Saleem T, Wessner LL, Scheithauer BW, Patterson K, Roach ES, Dreyer SJ, Fujikawa K, Bjornsson J, Bernstein J, Henske EP. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer. 1998;83:2208–2216. doi: 10.1002/(SICI)1097-0142(19981115)83:10<2208::AID-CNCR21>3.0.CO;2-K. [PubMed] [Cross Ref]
  • Robertson FM, Cendron M, Klauber GT, Harris BH. Renal cell carcinoma in association with tuberous sclerosis in children. J Pediatr Surg. 1996;31:729–730. doi: 10.1016/S0022-3468(96)90689-2. [PubMed] [Cross Ref]
  • Renshaw AA, Granter SR, Fletcher JA, Kozakewich HP, Corless CL, Perez-Atayde AR. Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes. Am J Surg Pathol. 1999;23:795–802. doi: 10.1097/00000478-199907000-00007. [PubMed] [Cross Ref]
  • Kobayashi T, Satoh K, Ohkawa M. Multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis. Acta Radiol. 2005;46:37–40. doi: 10.1080/02841850510020860. [PubMed] [Cross Ref]
  • Muir TE, Leslie KO, Popper H, Kitaichi M, Gagne E, Emelin JK, Vinters HV, Colby TV. Micronodular pneumocyte hyperplasia. Am J Surg Pathol. 1998;22:465–472. doi: 10.1097/00000478-199804000-00012. [PubMed] [Cross Ref]
  • Saito M, Yuasa T, Satoh S, Nanjo H, Tsuchiya N, Habuchi T. Developing multiple lung nodules in a renal transplant recipient with tuberous sclerosis who had undergone bilateral nephrectomy due to renal cell carcinomas. Int J Urol. 2008;15:257–258. doi: 10.1111/j.1442-2042.2007.01951.x. [PubMed] [Cross Ref]
  • Henske EP. The genetic basis of kidney cancer: why is tuberous sclerosis complex often overlooked? Curr Mol Med. 2004;4:825–831. doi: 10.2174/1566524043359610. [PubMed] [Cross Ref]
  • Mak BC, Yeung RS. The tuberous sclerosis complex genes in tumor development. Cancer Invest. 2004;22:588–603. doi: 10.1081/CNV-200027144. [PubMed] [Cross Ref]

Articles from BMC Clinical Pathology are provided here courtesy of BioMed Central